Haru Morita, President and CEO of Modalis Therapeutics Corporation, is scheduled to give a speech regarding
“The frontline of Gene editing and Modalis’ novel gene modulation therapies”
at the CBI Society Lecture hosted by The Chem-Bio Informatics Society (CBI Society) on November 19.
For more details, please see the following link.
※ The link will take you to a web page in Japanese.